| dc.contributor | IDIAP Jordi Gol |
| dc.contributor.author | Lestón Vázquez, Marta |
| dc.contributor.author | Gomez-Lumbreras, Ainhoa |
| dc.contributor.author | Prat Vallverdú, Oriol |
| dc.contributor.author | Giner-Soriano, Maria |
| dc.contributor.author | Morros, Rosa |
| dc.contributor.author | MARSAL MORA, JOSEP RAMON |
| dc.contributor.author | Vilaplana-Carnerero, Carles |
| dc.contributor.author | Vedia Urgell, Cristina |
| dc.date.accessioned | 2023-08-24T07:57:15Z |
| dc.date.available | 2023-08-24T07:57:15Z |
| dc.date.issued | 2023-08-22 |
| dc.identifier.citation | Lestón Vázquez M, Vilaplana-Carnerero C, Gomez-Lumbreras A, Prat-Vallverdu O, Ramon Marsal J, Vedia Urgell C, Soriano, et al. Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain. BMJ Open. 2023 Aug 22;13(8):e071335. |
| dc.identifier.issn | 2044-6055 |
| dc.identifier.uri | https://hdl.handle.net/11351/10143 |
| dc.description | Farmacología clínica; Atención primaria; Medicina reproductiva |
| dc.language.iso | eng |
| dc.publisher | BMJ |
| dc.relation.ispartofseries | BMJ Open;13(8) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Farmacologia clínica |
| dc.subject | Embaràs |
| dc.subject | Salut reproductiva |
| dc.subject | Medicaments - Administració |
| dc.subject.mesh | Pharmacology, Clinical |
| dc.subject.mesh | Pregnancy |
| dc.subject.mesh | Reproductive Health |
| dc.subject.mesh | Prescription Drugs |
| dc.title | Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1136/ bmjopen-2022-071335 |
| dc.subject.decs | farmacología clínica |
| dc.subject.decs | embarazo |
| dc.subject.decs | salud reproductiva |
| dc.subject.decs | medicamentos por prescripción |
| dc.relation.publishversion | https://doi.org/10.1136/bmjopen-2022-071335 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.authoraffiliation | [Lestón Vázquez M] Àrea del Medicament i Servei de Farmàcia, Gerència d'Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain. [Vilaplana-Carnerero C, Giner-Soriano M, Morros R] Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain. Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Gomez-Lumbreras A] College of Pharmacy, Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA. [Prat-Vallverdu O] Marketing farmacéutico & Investigación clínica, Barcelona, Spain. Former employee at IDIAPJGol, Barcelona, Spain. [Ramon Marsal J] Former employee at IDIAPJGol, Barcelona, Spain. RTI Health Solutions Barcelona, Barcelona, Spain. [Vedia Urgell C] Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain. Unitat de farmàcia, Servei d’Atenció Primària Barcelonès Nord i Maresme, Institut Català de la Salut (ICS), Generalitat de Catalunya, Badalona, Spain |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |